Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl or esketamine for traumatic pain trial
2022-500176-63-00Phase 3Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Acute traumatic pain comparing Fentanyl arm with Esketamine arm (2 arms). Primary endpoint: Change in numeric rating scale pain score at 10 minutes. Started Jan 2024; status: completed.
02
Drugs
fentanylesketamine
03
Conditions
Acute traumatic pain
Beyond the preview
Go deeper on 2022-500176-63-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500176-63-00.